We can change SCD

We can
change SCD

Our partnership is our strength

Treating sickle cell disease (SCD) is more than just treating acute complications. Treating SCD today means seeing the whole person and considering their lifelong goals. Monitoring for underlying progressive damage and managing overall health are crucial for optimal care. With a comprehensive and long-term approach to care,
we can create a different future together. 

Partnership is at the core of
bringing progress to SCD

Patients want somebody they can trust. We have to hold our hands out. We have to come honestly. We have to come patiently. It’s why we need partnerships based on trust, so we can get to a place where we can move forward together.”

Wally R. Smith, MD

Back
to Top
Learn how the progression
of SCD can affect each
patient differently


Discover current treatments for
SCD and treatments currently
being investigated, including
gene therapy

See how the challenges of
SCD can impact patients’ lives
and how you can start the
dialogue to move
comprehensive care forward

Together we can improve the care of sickle cell disease

Together we can
improve the care of
sickle cell disease

At bluebird bio, we believe that partnership can change the way people think about SCD, and feel that partnership is the way forward—partnership between physicians and people living with SCD, partnership between the SCD community and industry, and partnership that includes all of us.

Actual adult and pediatric physicians who treat SCD (as well as their patients who are living with SCD) helped inspire and inform the content of ChangeforSCD.com. Some of these patients and physicians are depicted throughout this website.

bluebird bio compensates these contributors for their time and the content they provide. Information provided by ChangeforSCD.com is for educational purposes and does not constitute medical advice.

Our partnership is our strength Our partnership is our
strength

Let’s change the way we view SCD and work
together for better outcomes in this disease.
Let’s change the way we view
SCD and work together
for better outcomes
in this disease.